Biotech

Biotech & Healthcare

Biotech Healthcare Essentials publishes only the best Biotech news and links, carefully hand-picked and curated by top biotech experts.

Biotech

Top news of the week: 06.11.2023.

Therapy
Disease
United States
Health care
Pharmaceutical drug
Biotechnology

@WSJ Health shared
On Nov 5, 2023
Fake tweet - https://www.juancole.com/2023/11/company-potentially-lifesaving.html
Open
How a Big Pharma Company Stalled a Potentially Lifesaving Vaccine in Pursuit of Bigger Profits

How a Big Pharma Company Stalled a Potentially Lifesaving Vaccine in Pursuit of Bigger Profits

By Anna Maria Barry-Jester | - ( ProPublica) - Ever since he was a medical student, Dr. Neil Martinson has confronted the horrors of tuberculosis, the world’s oldest and deadliest pandemic. ...

@WSJ Health shared
On Nov 1, 2023
Fake tweet - https://www.bostonherald.com/2023/10/31/crispr-could-kill-hiv-but-is-it-a-cure/
Open
CRISPR gene editing could kill HIV. But is it a cure?

CRISPR gene editing could kill HIV. But is it a cure?

The potential treatment, called EBT-101, is safe and caused no major side effects, Excision BioTherapeutics reported at a meeting in Brussels.

@WSJ Health shared
On Nov 1, 2023
Fake tweet - https://www.nbcnews.com/health/health-news/fda-moves-closer-sickle-cell-cure-uses-gene-editing-rcna123017
Open
FDA moves closer to sickle cell cure that uses gene editing

FDA moves closer to sickle cell cure that uses gene editing

If approved by the FDA, it would be the first medication on the market that uses the groundbreaking gene-editing tool CRISPR.

@WSJ Health shared
On Nov 5, 2023
Fake tweet - https://www.investorsobserver.com/news/qm-pr/5544864683353499
Open
Promontory Therapeutics Presents Data on Molecular Mechanisms of PT-112's Immunogenic Effects

Promontory Therapeutics Presents Data on Molecular Mechanisms of PT-112's Immunogenic Effects

Promontory Therapeutics Presents Data on Molecular Mechanisms of PT-112's Immunogenic Effects

@WSJ Health shared
On Nov 5, 2023
Fake tweet - https://www.etfdailynews.com/2023/11/04/reviewing-zivo-bioscience-nasdaqzivo-krystal-biotech-nasdaqkrys/
Open
Reviewing ZIVO Bioscience (NASDAQ:ZIVO) & Krystal Biotech (NASDAQ:KRYS)

Reviewing ZIVO Bioscience (NASDAQ:ZIVO) & Krystal Biotech (NASDAQ:KRYS)

ZIVO Bioscience (NASDAQ:ZIVO – Get Free Report) and Krystal Biotech (NASDAQ:KRYS – Get Free Report) are both medical companies, but which is the superior business? We will compare the two ...

@WSJ Health shared
On Nov 2, 2023
Fake tweet - https://www.forbes.com/sites/alexknapp/2023/11/01/innovationrx-the-vas-call-for-ai-tools/
Open
InnovationRx: The VA’s Call For AI Tools

InnovationRx: The VA’s Call For AI Tools

InnovationRx is your weekly digest of healthcare news. Sign up!

@WSJ Health shared
On Nov 6, 2023
Fake tweet - https://www.washingtonpost.com/health/2023/11/04/opioid-fentanyl-vaccine-antibody/
Open
The hunt quickens for vaccines and antibody therapies against opioids

The hunt quickens for vaccines and antibody therapies against opioids

The concept has long tantalized scientists: harnessing antibodies to block the dangerous effects of heroin, cocaine and nicotine.

@WSJ Health shared
On Nov 1, 2023
Fake tweet - https://www.nasa.gov/missions/station/previous-nasa-awards/
Open
Previous NASA Awards for In Space Production Applications

Previous NASA Awards for In Space Production Applications

As of spring 2023, NASA has invested greater than $60M in more than twenty In Space Production Applications (InSPA) awards to U.S. entities seeking to

Read more:
weekly 06.11.2023
View archives
Back to home

Subscribe to Biotech - Biotech & Healthcare.

Avoid an information overload and get the most trusted industry news hand-picked by the top Experts. Sign up for the weekly Biotech - Biotech & Healthcare.
Privacy Policy

Sign up for the weekly Biotech - Biotech & Healthcare newsletter

Never again miss anything or anyone that matter in Biotech

Sign up and receive the Biotech - Biotech & Healthcare weekly email newsletter directly to your inbox. Make more informed business decisions based on insight for the most trusted industry experts, faster.
Privacy Policy